Arginine protects muscle cells from wasting in vitro in an mTORC1-dependent and NO-independent manner

Amino Acids

Volumn 46, Issue 12, 2014, Pages 2643-2652

  Ham, Daniel J ^a   Caldow, Marissa K ^a   Lynch, Gordon S ^a   Koopman, René ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atrophy; C2C12; Protein synthesis; Starvation

Indexed keywords

ARGININE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; NITRIC OXIDE; TARGET OF RAPAMYCIN KINASE;

ANIMAL; CYTOLOGY; METABOLISM; MOUSE; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; ARGININE; MICE; MULTIPROTEIN COMPLEXES; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; NITRIC OXIDE; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84937511358     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1815-y     Document Type: Article

References (30)

1. Anderson JE (2000) A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell 11(5):1859-1874
2. Atherton PJ, Smith K, Etheridge T, Rankin D, Rennie MJ (2010) Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells. Amino Acids 38(5):1533-1539. doi: 10.1007/s00726-009-0377-x
3. Bauchart-Thevret C, Cui L, Wu G, Burrin DG (2010) Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide. Am J Physiol Endocrinol Metab 299(6):E899-E909. doi: 10.1152/ajpendo.00068.2010
4. Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J (2008) Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci USA 105(45):17414-17419. doi: 10.1073/pnas.0809136105
5. Collier SR, Casey DP, Kanaley JA (2005) Growth hormone responses to varying doses of oral arginine. Growth Horm IGF Res 15(2):136-139. doi: 10.1016/j.ghir.2004.12.004
6. Corradetti MN, Guan KL (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25(48):6347-6360. doi: 10.1038/sj.onc.1209885
7. Efeyan A, Zoncu R, Sabatini DM (2012) Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med 18(9):524-533. doi: 10.1016/j.molmed.2012.05.007
8. Evans WJ (1995) What is sarcopenia? J Gerontol A Biol Sci Med Sci 50:spec no 5-8
9. Evans RW, Fernstrom JD, Thompson J, Morris SM Jr, Kuller LH (2004) Biochemical responses of healthy subjects during dietary supplementation with l-arginine. J Nutr Biochem 15(9):534-539. doi: 10.1016/j.jnutbio.2004.03.005
10. Goodman CA, Mabrey DM, Frey JW, Miu MH, Schmidt EK, Pierre P, Hornberger TA (2011) Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique. Faseb J 25(3):1028-1039. doi: 10.1096/fj.10-168799
11. Goto C, Nishioka K, Umemura T, Jitsuiki D, Sakagutchi A, Kawamura M, Chayama K, Yoshizumi M, Higashi Y (2007) Acute moderate-intensity exercise induces vasodilation through an increase in nitric oxide bioavailability in humans. Am J Hypertens 20(8):825-830. doi: 10.1016/j.amjhyper.2007.02.014
12. Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J (1998) Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 273(23):14484-14494
13. Herningtyas EH, Okimura Y, Handayaningsih AE, Yamamoto D, Maki T, Iida K, Takahashi Y, Kaji H, Chihara K (2008) Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line. Biochim Biophys Acta 1780(10):1115-1120. doi: 10.1016/j.bbagen.2008.06.004
14. Jewell JL, Russell RC, Guan KL (2013) Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 14(3):133-139. doi: 10.1038/nrm3522
15. Jun T, Wennmalm A (1994) NO-dependent and -independent elevation of plasma levels of insulin and glucose in rats by l-arginine. Br J Pharmacol 113(2):345-348
16. Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 10(8):935-945. doi: 10.1038/ncb1753
17. Koh TJ, Tidball JG (1999) Nitric oxide synthase inhibitors reduce sarcomere addition in rat skeletal muscle. J Physiol 519(Pt 1):189-196
18. Koopman R, van Loon LJ (2009) Aging, exercise, and muscle protein metabolism. J Appl Physiol (1985) 106(6):2040-2048. doi: 10.1152/japplphysiol.91551.2008
19. Koopman R, Wagenmakers AJ, Manders RJ, Zorenc AH, Senden JM, Gorselink M, Keizer HA, van Loon LJ (2005) Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects. Am J Physiol Endocrinol Metab 288(4):E645-E653. doi: 10.1152/ajpendo.00413.2004
20. Koopman R, Ly CH, Ryall JG (2014) A metabolic link to skeletal muscle wasting and regeneration. Front Physiol 5:32. doi: 10.3389/fphys.2014.00032
21. Long JH, Lira VA, Soltow QA, Betters JL, Sellman JE, Criswell DS (2006) Arginine supplementation induces myoblast fusion via augmentation of nitric oxide production. J Muscle Res Cell Motil 27(8):577-584. doi: 10.1007/s10974-006-9078-1
22. Lynch GS, Schertzer JD, Ryall JG (2007) Therapeutic approaches for muscle wasting disorders. Pharmacol Ther 113(3):461-487
23. Merry TL, Steinberg GR, Lynch GS, McConell GK (2010) Skeletal muscle glucose uptake during contraction is regulated by nitric oxide and ROS independently of AMPK. Am J Physiol Endocrinol Metab 298(3):E577-E585. doi: 10.1152/ajpendo.00239.2009
24. Moinard C, Cynober L (2007) Citrulline: a new player in the control of nitrogen homeostasis. J Nutr 137(6 Suppl 2):1621S-1625S (pii 137/6/1621S)
25. Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P, Byfield MP, Backer JM, Natt F, Bos JL, Zwartkruis FJ, Thomas G (2005) Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 102(40):14238-14243. doi: 10.1073/pnas.0506925102
26. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22(2):159-168. doi: 10.1016/j.molcel.2006.03.029
27. Sellman JE, DeRuisseau KC, Betters JL, Lira VA, Soltow QA, Selsby JT, Criswell DS (2006) In vivo inhibition of nitric oxide synthase impairs upregulation of contractile protein mRNA in overloaded plantaris muscle. J Appl Physiol (1985) 100(1):258-265. doi: 10.1152/japplphysiol.00936.2005
28. Smith LW, Smith JD, Criswell DS (2002) Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload. J Appl Physiol (1985) 92(5):2005-2011. doi:
29. Tangphao O, Grossmann M, Chalon S, Hoffman BB, Blaschke TF (1999) Pharmacokinetics of intravenous and oral l-arginine in normal volunteers. Br J Clin Pharmacol 47(3):261-266
30. Wu G, Morris SM Jr (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336(Pt 1):1-17